z-logo
open-access-imgOpen Access
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
Author(s) -
James Hakim,
Victor Musiime,
Alex J. Szubert,
Jane Mallewa,
Abraham Siika,
Clara Agutu,
Simon Walker,
Sarah Pett,
Mutsa BwakuraDangarembizi,
Abbas Lugemwa,
Symon Kaunda,
Mercy Karoney,
Godfrey Musoro,
Sheila Kabahenda,
Kusum Nathoo,
Kathryn Maitland,
Anna Griffiths,
Margaret J. Thomason,
Cissy Kityo,
Peter Mugyenyi,
Andrew J. Prendergast,
A. Sarah Walker,
Diana M. Gibb
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1615822
Subject(s) - antiretroviral therapy , human immunodeficiency virus (hiv) , medicine , tuberculosis , virology , mortality rate , immunology , intensive care medicine , viral load , pathology
In sub-Saharan Africa, among patients with advanced human immunodeficiency virus (HIV) infection, the rate of death from infection (including tuberculosis and cryptococcus) shortly after the initiation of antiretroviral therapy (ART) is approximately 10%.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom